AIRNA
STANFORD, CA · Founded 2021 · CIK 0001894911 · Biotech · Private
RNA editing therapeutic medicines for rare and common genetic diseases
airna.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $1K
- 1 Form D · Nov 2021
- 59 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 0 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1234 | Factor Medical, LLC | — | $50K |
| 1235 | Auvi Labs, Inc. | — | $543K |
| 1236 | CANGET BIOTEKPHARMA, LLC | — | $25K |
| 1237 | AIRNA | — | $1K |
| 1238 | SCALMIBIO, INC | — | — |
| 1239 | Tessera Therapeutics | — | — |
| 1240 | Bluerock Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jin (Billy) LiDirector · Executive Officer
- Thorsten StafforstDirector · Executive Officer
- Paul VogelDirector · Executive Officer
Patents
- Chemically Modified Antisense Oligonucleotides (asos) And Compositions For Rna Editingapplication
- Chemically Modified Antisense Oligonucleotides (asos) And Compositions For Rna Editingapplication
- Site-directed Editing Of Rnaapplication
- Site-directed Editing Of Rnaapplication
- Chemically Modified Antisense Oligonucleotides (asos) And Compositions For Rna Editingapplication
- Site-directed Editing Of Rnaapplication
- Chemically Modified Antisense Oligonucleotides (asos) And Compositions For Rna Editingapplication
- Site-directed Editing Of Rnaapplication
- Site-directed Editing Of Rnaapplication
- Chemically Modified Antisense Oligonucleotides (asos) And Compositions For Rna Editingapplication
- Site-directed Editing Of Rnaapplication
- Site-directed Editing Of Rnaapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.